Clinical trials
Terminated Phase 2 Brain Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2013 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2021 | 1 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Affiris AG | 1 |
| Genentech, Inc. | 1 |
| GlaxoSmithKline | 1 |
| Indiana University | 1 |
| Inmune Bio, Inc. | 1 |
| Neurologix, Inc. | 1 |
| Ochsner Health System | 1 |
| ReNeuron Limited | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Brain Diseases | 8 |
| Alzheimer Disease | 4 |
| Dementia | 4 |
| Nervous System Diseases | 4 |
| Neurodegenerative Diseases | 4 |
| Central Nervous System Diseases | 3 |
| Mental Disorders | 3 |
| Neurocognitive Disorders | 2 |
| Tauopathies | 2 |
| Basal Ganglia Diseases | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.